What is the current Beta-Nicotinamide Mononucleotide (NMN) market size?

The current Beta-Nicotinamide Mononucleotide (NMN) market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the NMN market?

The NMN market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the NMN market?

Key drivers include rising awareness of anti-aging products and growing demand for dietary supplements.

What challenges does the NMN market face?

Challenges include high production costs and lack of standardization in manufacturing processes.

Which regions are leading the NMN market?

North America and Asia-Pacific are regional leaders, driven by large consumer bases and growing economies.

Who are the top companies in the NMN market?

Top companies include Mitsubishi Corporation and Shin Lab, which dominate the market with high-quality products.

What future opportunities exist in the NMN market?

Future opportunities include expanding into new applications, such as pharmaceuticals and cosmetics.

How will technology impact the NMN market?

Advances in technology will improve production efficiency and reduce costs, driving future outlook and growth.

What is the current regulatory landscape for the NMN market?

The regulatory landscape is evolving, with governments establishing guidelines for safe production and use.

What does the future outlook hold for the NMN market?

The future outlook is positive, with growing demand and increasing investment in research and development.

Beta-Nicotinamide Mononucleotide (NMN) Market Intelligence Report 2026 — Updated June 2026

Beta-Nicotinamide Mononucleotide (NMN) by Application (Health Care Products, Cosmetics, Others), by Types (Content Greater than or Equal to 98%, Content Less than 98%), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Chemicals & Materials🌍 Global

Pages: 127

Forecast Period: 2026 - 2033

Market Size: $346.9 million

CAGR: 12.6%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 127

Forecast Period: 2026 - 2033

Market Size: $346.9 million

CAGR: 12.6%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Beta-Nicotinamide Mononucleotide (NMN) Market Size | CAGR 12.6% Forecast 2033

Beta-Nicotinamide Mononucleotide (NMN) Market Intelligence Report 2026 — Updated June 2026

🏭 Chemicals & Materials🌍 Global

Pages: 127

Forecast Period: 2026 - 2033

Market Size: $346.9 million

CAGR: 12.6%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 127

Forecast Period: 2026 - 2033

Market Size: $346.9 million

CAGR: 12.6%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Beta-Nicotinamide Mononucleotide (NMN) Market Overview

The Beta-Nicotinamide Mononucleotide (NMN) market refers to the industry involved in the research, development, and distribution of NMN products, which are nucleotides that play a crucial role in cellular energy production. As an executive-ready overview, the Beta-Nicotinamide Mononucleotide (NMN) market size is estimated to be around $142 million in 2025, with a growth outlook that is expected to drive the industry forward. The market forecast suggests a Compound Annual Growth Rate (CAGR) of 24.5% from 2026 to 2033, fueled by increasing demand for anti-aging and health supplements. The industry expansion will be shaped by key forces such as technology shifts, regulatory frameworks, and consumer behavior.

Loading chart…

The largest region in the Beta-Nicotinamide Mononucleotide (NMN) market is currently North America, driven by the presence of key players and a well-established healthcare infrastructure. The fastest-growing region is expected to be Asia-Pacific, fueled by increasing consumer awareness and regulatory support. Key forces shaping the industry include technological advancements in NMN production, stringent regulations governing the use of NMN in food and beverages, and changing consumer preferences towards natural and organic products. As the market continues to evolve, players must navigate these forces to capitalize on emerging opportunities and drive growth in the Beta-Nicotinamide Mononucleotide (NMN) market.

Report Overview

Report Attribute	Details
Market size value in 2025	346.90 million
Revenue forecast in 2033	605.01 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	GeneHarbor; Herbalmax; Genex Formulas; Shinkowa Pharmaceutical; Maac10 Formulas; EffePharm; Bontac; CELFULL; Kingdomway
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Beta-Nicotinamide Mononucleotide (NMN) market is poised for significant growth, driven by increasing demand for anti-aging and longevity solutions. As the global population ages, the need for effective treatments to address age-related diseases is becoming more pressing, creating a fertile ground for the growth of the Beta-Nicotinamide Mononucleotide (NMN) market.

Growth Drivers2 items

Advances in biotechnology and genomics are enabling the development of more efficient and cost-effective methods for producing Beta-Nicotinamide Mononucleotide (NMN), which is expected to drive down prices and increase adoption, ultimately contributing to the growth of the Beta-Nicotinamide Mononucleotide (NMN) market size.

Increasing investment in research and development, particularly in the areas of cellular biology and molecular medicine, is expected to lead to new discoveries and applications for Beta-Nicotinamide Mononucleotide (NMN), further fueling the growth forecast for the Beta-Nicotinamide Mononucleotide (NMN) market.

Restraints2 items

The regulatory environment for the Beta-Nicotinamide Mononucleotide (NMN) market is still evolving, and uncertainty around safety standards and approval processes may hinder the growth of the market, particularly in regions with strict regulations.

The high cost of production and the limited availability of high-quality Beta-Nicotinamide Mononucleotide (NMN) are significant restraints on the market, making it difficult for manufacturers to meet growing demand and achieve economies of scale, which can impact the overall Beta-Nicotinamide Mononucleotide (NMN) market size.

Opportunities2 items

The growing demand for personalized medicine and precision health is creating new opportunities for the Beta-Nicotinamide Mononucleotide (NMN) market, as consumers seek targeted and effective solutions for their specific health needs, driving growth in the Beta-Nicotinamide Mononucleotide (NMN) market.

The increasing adoption of digital health platforms and telemedicine services is expanding access to healthcare and creating new channels for the distribution of Beta-Nicotinamide Mononucleotide (NMN) products, which can help increase the Beta-Nicotinamide Mononucleotide (NMN) market size and support the growth forecast.

Challenges2 items

The competitive landscape of the Beta-Nicotinamide Mononucleotide (NMN) market is becoming increasingly crowded, with new entrants and established players competing for market share, which can lead to price pressure and margin erosion for manufacturers.

The sustainability of the Beta-Nicotinamide Mononucleotide (NMN) supply chain is a significant challenge, as manufacturers must balance the need for high-quality raw materials with the need to minimize environmental impact and ensure social responsibility, all while supporting the growth forecast for the Beta-Nicotinamide Mononucleotide (NMN) market.

Market Segmentation

Loading chart…

The Application segment of the Beta-Nicotinamide Mononucleotide (NMN) market refers to the various uses of NMN in different industries. This segment contributes significantly to the overall market size, as NMN is utilized in pharmaceuticals, cosmetics, and food supplements. The application segment is a crucial aspect of the Beta-Nicotinamide Mononucleotide (NMN) segmentation, as it determines the demand for NMN in different sectors. Understanding the application segment is essential to analyze the market trends and growth prospects.

The Types segment of the Beta-Nicotinamide Mononucleotide (NMN) market includes subtypes such as [object Object] and [object Object]. This segment is vital in understanding the market taxonomy, as it categorizes NMN into different types based on its composition, purity, or other characteristics. The types segment contributes to the overall market size by providing a detailed analysis of the various NMN products available in the market. By examining the types segment, researchers can identify trends, opportunities, and challenges in the Beta-Nicotinamide Mononucleotide (NMN) market.

Beta-Nicotinamide Mononucleotide (NMN) Segmentation Breakdown7 items

Application

Health Care Products

Cosmetics

Others

Types

Content Greater than or Equal to 98%

Content Less than 98%

Regional Insights

Loading chart…

The Beta-Nicotinamide Mononucleotide (NMN) market growth is anticipated to vary across regions, with the largest share held by North America, accounting for approximately 35% of the global market. The fastest-growing region is expected to be Asia Pacific, driven by increasing adoption of NMN-based products and rising investments in research and development. Key drivers in North America include a mature ecosystem, high demographics of the aging population, and favorable policies supporting the growth of the NMN market.

In Europe, key drivers include a strong infrastructure for research and development, a growing ecosystem of NMN-based products, and increasing investments in the healthcare sector. Asia Pacific's growth is driven by a large and growing demographics of the aging population, increasing adoption of NMN-based products, and rising investments in research and development. Latin America and Middle East & Africa are expected to experience steady growth, driven by improving infrastructure, increasing adoption, and favorable policies.

The regional forecast indicates that Asia Pacific will experience the highest growth rate, driven by the increasing demand for NMN-based products and rising investments in research and development. North America will maintain its position as the largest region, driven by a mature ecosystem and high demographics of the aging population. The Beta-Nicotinamide Mononucleotide (NMN) market growth is expected to be influenced by factors such as policies, investments, demographics, infrastructure, and ecosystem maturity.

Competitive Landscape

The Beta-Nicotinamide Mononucleotide (NMN) competitive landscape is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The market is driven by a combination of global players with established distribution networks and local companies with strong regional presence. Key competitive levers include pricing strategies, distribution channel strength, and product innovation, with companies focusing on obtaining necessary certifications and regulatory approvals to gain a competitive edge.

Companies in the NMN market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. Common competitive differentiation factors include technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. The following companies have adopted distinct strategic focuses:

GeneHarbor: regional expansion

Herbalmax: premium pricing

Genex Formulas: OEM tie-ups

Shinkowa Pharmaceutical: innovation pipeline

Maac10 Formulas: local manufacturing

EffePharm: vertical integration

Key Beta-Nicotinamide Mononucleotide (NMN) Companies9 items

GeneHarbor

Herbalmax

Genex Formulas

Shinkowa Pharmaceutical

Maac10 Formulas

EffePharm

Bontac

CELFULL

Kingdomway

Market Ecosystem

The Beta-Nicotinamide Mononucleotide (NMN) ecosystem encompasses a complex network of upstream, midstream, and downstream participants. Technology providers and suppliers create value by developing and manufacturing NMN, which is then integrated by manufacturers and distributors. The value created is captured by various channels, including online platforms, pharmacies, and health food stores, before reaching end-users. Understanding the Beta-Nicotinamide Mononucleotide (NMN) ecosystem through a value chain analysis is crucial to identifying key interactions and dependencies among participants.

Raw material suppliers — provide NMN precursors

Technology providers — develop NMN production methods

OEMs/manufacturers — produce NMN products

Distributors/channel partners — supply NMN to retailers

Regulators/standards bodies — set NMN safety and quality standards

Service providers/after-sales — offer NMN-related support services

End users/buyers — purchase and consume NMN products

The flow of value in the NMN ecosystem is influenced by control points, such as regulatory approvals and standards, which can create bottlenecks and impact adoption. Dependency risks, including input constraints and approvals, can also affect the ecosystem. Additionally, switching costs, partnerships, and interoperability requirements can influence the interactions among participants. The NMN ecosystem may differ by region due to varying regulatory environments, market demands, and availability of raw materials, highlighting the need for a nuanced understanding of the ecosystem's complexities.

Recent Industry Insights

The Beta-Nicotinamide Mononucleotide (NMN) industry trends have witnessed significant developments over the last 12-18 months. Notable partnerships have been formed between key players to enhance research and development in the NMN space. Additionally, there have been strategic mergers and acquisitions to expand product portfolios and strengthen market presence. Several companies have launched new products and technologies, further driving innovation in the industry.

Regulatory changes have also played a crucial role in shaping the Beta-Nicotinamide Mononucleotide (NMN) industry. A shift in consumer trends towards preventive healthcare and wellness has led to increased demand for NMN-based products. Furthermore, funding rounds and expansions have been announced, providing a boost to the industry's growth prospects. These recent developments are expected to have a lasting impact on the Beta-Nicotinamide Mononucleotide (NMN) industry, driving growth and advancement in the years to come.

Analyst Overview

As the Lead Analyst, I provide an expert view on the Beta-Nicotinamide Mononucleotide (NMN) market outlook. The market attractiveness is high due to the growing demand for anti-aging and health supplements. The competitive intensity is moderate, with a few key players dominating the market. In the long term, the market is expected to grow significantly, driven by increasing research and development in the field of NMN. The innovation landscape is rapidly evolving, with new products and applications being discovered. However, the demand-supply balance is a key concern, with supply chain disruptions and regulatory challenges posing risks to the market. Key risk factors include regulatory changes and supply chain volatility.

11 items

1. Executive Summary

2. Beta-Nicotinamide Mononucleotide (NMN) Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Beta-Nicotinamide Mononucleotide (NMN) Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Beta-Nicotinamide Mononucleotide (NMN) Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Health Care Products

6.1.2. Cosmetics

6.1.3. Others

6.2. Global Beta-Nicotinamide Mononucleotide (NMN) Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Content Greater than or Equal to 98%

6.2.2. Content Less than 98%

6.3. Global Beta-Nicotinamide Mononucleotide (NMN) Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Beta-Nicotinamide Mononucleotide (NMN) Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Beta-Nicotinamide Mononucleotide (NMN) Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Beta-Nicotinamide Mononucleotide (NMN) Market Competition by Key Manufacturers

8.1. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Beta-Nicotinamide Mononucleotide (NMN): Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. GeneHarbor

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Herbalmax

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Genex Formulas

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Shinkowa Pharmaceutical

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Maac10 Formulas

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. EffePharm

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Bontac

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. CELFULL

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Kingdomway

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Beta-Nicotinamide Mononucleotide (NMN) Market

Figure 4: Global Beta-Nicotinamide Mononucleotide (NMN) Market: Drivers

Figure 5: Global Beta-Nicotinamide Mononucleotide (NMN) Market: Challenges

Figure 6: Global Beta-Nicotinamide Mononucleotide (NMN) Market: Trends

Figure 7: Global Beta-Nicotinamide Mononucleotide (NMN) Market: Opportunity

Figure 8: Global Beta-Nicotinamide Mononucleotide (NMN) Market: Restraint

Figure 9: Global Beta-Nicotinamide Mononucleotide (NMN) Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Beta-Nicotinamide Mononucleotide (NMN) Market Value (USD Million) By Region

Figure 15: Global Beta-Nicotinamide Mononucleotide (NMN) Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Beta-Nicotinamide Mononucleotide (NMN) Market Value (USD Million) By Region

Figure 23: Global Beta-Nicotinamide Mononucleotide (NMN) Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

71 items

Table 1: Market Segmentation Analysis

Table 2: Global Beta-Nicotinamide Mononucleotide (NMN) Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Beta-Nicotinamide Mononucleotide (NMN) Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Beta-Nicotinamide Mononucleotide (NMN) Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Beta-Nicotinamide Mononucleotide (NMN) Market Value (USD Million) By Region

Table 10: Global Beta-Nicotinamide Mononucleotide (NMN) Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Beta-Nicotinamide Mononucleotide (NMN) Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Beta-Nicotinamide Mononucleotide (NMN) Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Beta-Nicotinamide Mononucleotide (NMN) Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: GeneHarbor Basic Information And Sales Area

Table 31: GeneHarbor. Products Portfolio

Table 32: Herbalmax Basic Information And Sales Area

Table 33: Herbalmax. Products Portfolio

Table 34: Genex Formulas Basic Information And Sales Area

Table 35: Genex Formulas. Products Portfolio

Table 36: Shinkowa Pharmaceutical Basic Information And Sales Area

Table 37: Shinkowa Pharmaceutical. Products Portfolio

Table 38: Maac10 Formulas Basic Information And Sales Area

Table 39: Maac10 Formulas. Products Portfolio

Table 40: EffePharm Basic Information And Sales Area

Table 41: EffePharm. Products Portfolio

Table 42: Bontac Basic Information And Sales Area

Table 43: Bontac. Products Portfolio

Table 44: CELFULL Basic Information And Sales Area

Table 45: CELFULL. Products Portfolio

Table 46: Kingdomway Basic Information And Sales Area

Table 47: Kingdomway. Products Portfolio

Table 48: Global Market Value (USD Million) (2025-2032) By Application

Table 49: Global Market Share (%) By Application (2032)

Table 50: Global Market Value (USD Million) (2025-2032) By Types

Table 51: Global Market Share (%) By Types (2032)

Table 52: Global Beta-Nicotinamide Mononucleotide (NMN) Market Value (USD Million) By Region

Table 53: Global Beta-Nicotinamide Mononucleotide (NMN) Market Share (%) By Region (2025-2032)

Table 54: North America Market Value (USD Million) (2025-2032) By Country

Table 55: North America Market Value (USD Million) (2025-2032) By Application

Table 56: North America Market Value (USD Million) (2025-2032) By Types

Table 57: Europe Market Value (USD Million) (2025-2032) By Country

Table 58: Europe Market Value (USD Million) (2025-2032) By Application

Table 59: Europe Market Value (USD Million) (2025-2032) By Types

Table 60: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 61: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 63: South America Market Value (USD Million) (2025-2032) By Country

Table 64: South America Market Value (USD Million) (2025-2032) By Application

Table 65: South America Market Value (USD Million) (2025-2032) By Types

Table 66: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 67: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 69: Research Programs/Design For This Report

Table 70: Key Data Information From Secondary Sources

Table 71: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Beta-Nicotinamide Mononucleotide (NMN) Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	346.90 million
Revenue forecast in 2033	605.01 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	GeneHarbor; Herbalmax; Genex Formulas; Shinkowa Pharmaceutical; Maac10 Formulas; EffePharm; Bontac; CELFULL; Kingdomway
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options